145 related articles for article (PubMed ID: 28098871)
41. Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor.
Mantha AJ; Hanson JE; Goss G; Lagarde AE; Lorimer IA; Dimitroulakos J
Clin Cancer Res; 2005 Mar; 11(6):2398-407. PubMed ID: 15788691
[TBL] [Abstract][Full Text] [Related]
42. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.
Kudryavtseva AV; Fedorova MS; Zhavoronkov A; Moskalev AA; Zasedatelev AS; Dmitriev AA; Sadritdinova AF; Karpova IY; Nyushko KM; Kalinin DV; Volchenko NN; Melnikova NV; Klimina KM; Sidorov DV; Popov AY; Nasedkina TV; Kaprin AD; Alekseev BY; Krasnov GS; Snezhkina AV
BMC Genet; 2016 Dec; 17(Suppl 3):156. PubMed ID: 28105937
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of cell signaling by the combi-nitrosourea FD137 in the androgen independent DU145 prostate cancer cell line.
Qiu Q; Dudouit F; Banerjee R; McNamee JP; Jean-Claude BJ
Prostate; 2004 Apr; 59(1):13-21. PubMed ID: 14991862
[TBL] [Abstract][Full Text] [Related]
44. Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.
Chen N; Fang W; Zhan J; Hong S; Tang Y; Kang S; Zhang Y; He X; Zhou T; Qin T; Huang Y; Yi X; Zhang L
J Thorac Oncol; 2015 Jun; 10(6):910-23. PubMed ID: 25658629
[TBL] [Abstract][Full Text] [Related]
45. Gefitinib inhibits sodium phosphate co-transporter III isoform 1 in a model of human malignant glioma.
Puech C; Prevot N; Perek N
Anticancer Res; 2014 Nov; 34(11):6527-35. PubMed ID: 25368255
[TBL] [Abstract][Full Text] [Related]
46. Targeting Pyruvate Kinase M2 and Hexokinase II, Pachymic Acid Impairs Glucose Metabolism and Induces Mitochondrial Apoptosis.
Miao G; Han J; Zhang J; Wu Y; Tong G
Biol Pharm Bull; 2019 Jan; 42(1):123-129. PubMed ID: 30381614
[TBL] [Abstract][Full Text] [Related]
47. Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.
Lichtner RB; Menrad A; Sommer A; Klar U; Schneider MR
Cancer Res; 2001 Aug; 61(15):5790-5. PubMed ID: 11479217
[TBL] [Abstract][Full Text] [Related]
48. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
[TBL] [Abstract][Full Text] [Related]
49. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
50. EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts.
Geoerger B; Gaspar N; Opolon P; Morizet J; Devanz P; Lecluse Y; Valent A; Lacroix L; Grill J; Vassal G
Int J Cancer; 2008 Jul; 123(1):209-16. PubMed ID: 18386816
[TBL] [Abstract][Full Text] [Related]
51. Signaling mechanisms that mediate invasion in prostate cancer cells.
Bonaccorsi L; Marchiani S; Muratori M; Carloni V; Forti G; Baldi E
Ann N Y Acad Sci; 2004 Dec; 1028():283-8. PubMed ID: 15650253
[TBL] [Abstract][Full Text] [Related]
52. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
53. Molecular mechanisms of Polygonatum cyrtonema lectin-induced apoptosis and autophagy in cancer cells.
Liu B; Cheng Y; Bian HJ; Bao JK
Autophagy; 2009 Feb; 5(2):253-5. PubMed ID: 19139634
[TBL] [Abstract][Full Text] [Related]
54. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-98 Suppress Warburg Effect by Targeting HK2 in Colon Cancer Cells.
Zhu W; Huang Y; Pan Q; Xiang P; Xie N; Yu H
Dig Dis Sci; 2017 Mar; 62(3):660-668. PubMed ID: 28025745
[TBL] [Abstract][Full Text] [Related]
56. Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells.
Ligęza J; Ligęza J; Klein A
Acta Biochim Pol; 2011; 58(3):391-6. PubMed ID: 21887406
[TBL] [Abstract][Full Text] [Related]
57. XBP1 silencing decreases glioma cell viability and glycolysis possibly by inhibiting HK2 expression.
Liu Y; Hou X; Liu M; Yang Z; Bi Y; Zou H; Wu J; Che H; Li C; Wang X; Wang K; Zhong C; Zhang J; Yu T; Bian Q; Chai S; Liu H; Ai J; Zhao S
J Neurooncol; 2016 Feb; 126(3):455-62. PubMed ID: 26680227
[TBL] [Abstract][Full Text] [Related]
58. Polygonatum cyrtonema lectin induces murine fibrosarcoma L929 cell apoptosis via a caspase-dependent pathway as compared to Ophiopogon japonicus lectin.
Zhang ZT; Peng H; Li CY; Liu JJ; Zhou TT; Yan YF; Li Y; Bao JK
Phytomedicine; 2010 Dec; 18(1):25-31. PubMed ID: 20655713
[TBL] [Abstract][Full Text] [Related]
59. Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro.
Huang ZH; Zheng HF; Wang WL; Wang Y; Zhong LF; Wu JL; Li QX
Mol Med Rep; 2015 Mar; 11(3):2125-8. PubMed ID: 25394789
[TBL] [Abstract][Full Text] [Related]
60. Cross interference with TNF-alpha-induced TAK1 activation via EGFR-mediated p38 phosphorylation of TAK1-binding protein 1.
Shin MS; Shinghirunnusorn P; Sugishima Y; Nishimura M; Suzuki S; Koizumi K; Saiki I; Sakurai H
Biochim Biophys Acta; 2009 Jul; 1793(7):1156-64. PubMed ID: 19393267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
